UnknownNot Applicable

Paraclinoid ANeurysm Prospectively Driven ObseRvational Analysis (PANDORA) Study

South Korea682 participantsStarted 2015-01

Plain-language summary

The optimal consensus concerning treatment of incidental small paraclinoid unruptured intracranial aneurysms (UIAs) remains controversial. The aim of this prospective study is to reveal the natural history of small paraclinoid UIAs with the goal of informing the treatment plan.

Who can participate

Age range

20 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with newly diagnosed small unruptured paraclinoid aneurysms who agreed to participate. * 20years old or more * less than 5mm in maximum diameter * neurological status of patients should be satisfied with less than modified Rankin score 2 or more than 70 in Karnofsky performance score Exclusion Criteria: * patients had previous subarachnoid hemorrhage that could be related to the rupture of paraclinoid aneurysm. * traumatic, infectious or dissecting aneurysms * fusiform aneurysms * aneurysms that related to other vascular disease or brain tumor * aneurysm that associated with the atherosclerotic change of a parent artery

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Number of increased maximal diameter of enrolled paraclinoid aneurysms on follow up MRA or CTA

Timeframe: within 5years after enrollment

Number of rupture of enrolled paraclinoid aneurysms

Timeframe: within 5years after enrollment

Trial details

NCT IDNCT02553109

SponsorSeoul National University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-12

View on ClinicalTrials.gov More Unruptured Aneurysm of Carotid Artery trials

Who can participate

Age range

20 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.